Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Subcutaneous infliximab maintained remission among patients with inflammatory bowel disease who ...
The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
Subcutaneous pembrolizumab has been approved across all indications, cutting chair and administration times with a median ...
An infliximab biosimilar (infliximab-axxq) delivered via subcutaneous injection was superior to intravenous vedolizumab (Entyvio) for induction and maintenance therapy of Crohn's disease (CD), ...
Please provide your email address to receive an email when new articles are posted on . A recent comparative analysis shed light on the differences between subcutaneous panniculitis-like T-cell ...
When Eli Lilly gained emergency use approval for its COVID-19 antibody treatment last October, it was a major triumph for a company aiming to satisfy a desperate need around the world. But eight ...
Opdivo Qvantig received FDA approval for all previously approved indications in solid tumors. The Food and Drug Administration (FDA) approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), a ...
LEQEMBI IQLIK is the first and only anti-amyloid treatment to offer an at-home injection to help patients and care partners continue to treat this progressive, relentless disease after initial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback